ClinicalTrials.gg
Not yet recruitingNCT07802444DDEALAPPTUpdated Sep 3, 2026

Do Different Arousal Levels Affect Pressure Pain Thresholds?

An interventional study of Emotional high arousing intervention and Low arousal intervention in High Arousing Positive Emotion and Low Arousing Positive Condition, sponsored by Linnaeus University. Not yet recruiting. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-03.

Sponsored by Linnaeus University · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

This study examines whether emotional arousal level alone, while maintaining positive emotional valence, can influence pressure pain thresholds (PPTs) in healthy adults. Pain perception is closely linked to emotional processes, and prior research indicates that emotional valence affects PPTs. However, the specific role of arousal level remains unclear. The study aims to isolate arousal by comparing high arousal positive emotion (humor) with low arousal positive emotion (pleasant video), and a no emotion control condition.

A total of 120 healthy participants will be randomly assigned to one of three groups: (1) humor induction (high valence, moderate-high arousal), (2) pleasant emotion induction (high valence, low arousal), or (3) mind wandering control. All participants will first view a neutral baseline video to standardize mood. PPTs will be measured bilaterally at the m. trapezius and m. tibialis anterior using a Somedic algometer (1 cm² probe, 30 kPa/s application rate). Three consecutive PPT measurements per site will be averaged. After the emotional induction (2:30 minutes), PPTs will be reassessed at all four sites.

Emotional responses will be validated using the Self Assessment Manikin (SAM) scale to measure valence and arousal. The humor video has been validated in earlier studies, whereas the pleasant low arousal video will be validated in a pre study. Inclusion criteria are age ≥18 and fluency in Swedish; exclusion criteria include pain during testing and known neurological disease.

The primary objective is to determine whether high arousal with positive valence increases PPTs (hypoalgesia) and whether low arousal with positive valence decreases PPTs (sensitization).

Statistical analyses include repeated measures t tests (Bonferroni corrected) and mixed model ANOVA. Nonparametric tests will be used if PPT distributions deviate from normality.

02

Conditions studied

  • High Arousing Positive Emotion
  • Low Arousing Positive Condition

Keywords

  • Emotion
  • Pressure Pain Thresholds
03

In context

Lead sponsor

Linnaeus University is the lead sponsor of 29 studies on the registry; 14 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Above 18 years of age, fluent in Swedish.

Exclusion criteria

Exclusion Criteria:

  • Pain anywhere in body during the test session, known neurological disease.
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
120 participants (estimated)

Study arms

  • Experimental
    High arousal positive intervention

    A high arousing video with positive content (humor) will be presented.

    Behavioral: Emotional high arousing intervention

  • Experimental
    Low arousal positive intervention

    A low arousing video with positive content will be presented.

    Behavioral: Low arousal intervention

Interventions

  • BehavioralEmotional high arousing intervention

    The high arousing video will be presented for 2.30 minutes.

  • BehavioralLow arousal intervention

    A low arousing positive video will be presented for 2.30 min.

06

What researchers measure

Primary outcomes

  1. Pressure Pain Thresholds will be tested in m. trapezius and m. tibialis anterior using a hand-held algometer.

    Pressure Pain Thresholds will be tested in m. trapezius and m. tibialis anterior bilaterally using a hand-held algometer.

    Time frame: A baseline video is presented and immediately after PPT measurements are conducted. After that the intervention video is presented and immediately after PPT measurements are conducted.

  2. Pressure Pain Thresholds

    PPTs

    Time frame: From experiencing the video and two minutes after

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided — We will share anonymous data in an open science platform after the finished data collection.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 3, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07802444
Lead sponsor
Linnaeus University
Responsible party
Helena Gunnarsson (Principal investigator, Linnaeus University) — Principal investigator
First posted
Sep 3, 2026
Start date
Oct 1, 2026 (estimated)
Primary completion
May 31, 2027 (estimated)
Completion
May 31, 2027 (estimated)
Last update
Sep 3, 2026

Study contacts

Helena Gunnarsson, PhD
Contact
helena.gunnarsson@lnu.se
+46708432509

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion